Efthymios Deliargyris
2018
In 2018, Efthymios Deliargyris earned a total compensation of $432.9K as Former Chief Medical Officer at Dipexium Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $57,363 |
|---|---|
| Option Awards | $157,850 |
| Salary | $115,532 |
| Other | $102,167 |
| Total | $432,912 |
Deliargyris received $157.9K in option awards, accounting for 36% of the total pay in 2018.
Deliargyris also received $57.4K in non-equity incentive plan, $115.5K in salary and $102.2K in other compensation.
Rankings
In 2018, Efthymios Deliargyris' compensation ranked 12,321st out of 14,244 executives tracked by ExecPay. In other words, Deliargyris earned more than 13.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,321 out of 14,244 | 14th |
Division Manufacturing | 4,979 out of 5,758 | 14th |
Major group Chemicals And Allied Products | 1,878 out of 2,119 | 11th |
Industry group Drugs | 1,606 out of 1,808 | 11th |
Industry Pharmaceutical Preparations | 1,230 out of 1,382 | 11th |
Source: SEC filing on September 25, 2020.
Deliargyris' colleagues
We found three more compensation records of executives who worked with Efthymios Deliargyris at Dipexium Pharmaceuticals in 2018.